Monday, February 13, 2012
Just Diagnosed with Cancer? Chat with Experts

All SharePosts Relating To "herceptin"

Expert_badge PJ Hamel

PJ Hamel

(Profile)
Author, breast cancer survivor

New Treatment for HER2+ Survivors

For certain women with metastatic HER2+ breast cancer, life just got a little bit brighter – literally. On January 29, the FDA granted approval to a new combination drug therapy – Tykerb (lapatinib), and Femara (letrozole) – for post-menopausal women with estrogen-receptive, HER2-positive (HER2+) metastatic breast... Read moreChevron
Expert_badge PJ Hamel

PJ Hamel

(Profile)
Author, breast cancer survivor

New Drug Combining Herceptin, Maytansine Shows Improved Survival and Fewer Side Effects

The annual San Antonio Breast Cancer Symposium (SABCS), held last month, is the premier scientific symposium in the world for breast oncologists, breast cancer researchers, and associated healthcare professionals. Last year’s session included the presentation of over 1,000 scientific papers related to breast cancer; this year’s agenda... Read moreChevron
Expert_badge Kevin Knopf, MD

Kevin Knopf, MD

(Profile)
Medical Oncologist

The Advantages and Disadvantages of Adjuvant Chemotherapy for Breast Cancer

Data presented at the San Antonio Breast Cancer Symposium show that basically all women with HER2+ breast cancers benefit from adjuvant chemotherapy/Herceptin due to their worse prognosis. In my mind, however, there is no more controversial area in breast cancer than in which patients truly benefit from receiving adjuvant chemotherapy, among women... Read moreChevron
Expert_badge Kevin Knopf, MD

Kevin Knopf, MD

(Profile)
Medical Oncologist

All HER2 Positive Breast Cancers Should Get Adjuvant Chemotherapy and Herceptin

From the San Antonio Breast Conference in December, new data shows a higher than predicted rate of breast cancer recurrence even with very small breast cancers that are HER2 positive. The data is from the first large study to analyze early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller. All these women would... Read moreChevron
posted 02/09/2009, comments (0)|
Expert_badge Kevin Knopf, MD

Kevin Knopf, MD

(Profile)
Medical Oncologist

Reading your Pathology Report: HER2 Status, Growth Fraction, Angiolymphatic Invasion

In my previous two posts on understanding your pathology report, we covered histology, margin status, grade, as well as size, lymph node status, Estrogen Receptor and Progesterone Receptor. Now I'll cover just a few more items to finish up our tour of the breast cancer pathology report, including HER2 Status, how fast the cancer is dividing, and... Read moreChevron
posted 01/14/2009, comments (0)|

Ask a Question

Get answers from our experts and community members.

Btn_ask_question_med
View all questions (6482) >